Myopia
909
82
136
575
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
305 trials with published results (34%)
Research Maturity
575 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
2.0%
18 terminated out of 909 trials
97.0%
+10.5% vs benchmark
8%
77 trials in Phase 3/4
53%
305 of 575 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 575 completed trials
Clinical Trials (909)
[Trial of device that is not approved or cleared by the U.S. FDA]
A Comparative Study of the Efficacy of Myopia Control Lenses With Different Mechanisms on Controlling Myopia Progression in Patients With Intermittent Exotropia
Longitudinal Measurements of Visual Diet in Children
A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control
Efficacy of a Novel Myopia Defocus Spectacle Lens in School-Aged Children
Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control
Atropine Alone vs Atropine Plus Bifocal Spectacles for Myopia Control in Children
Virtual Far-sight Reading Device for Myopia Intervention Among Pre-myopic Children
Observational Survey Study on the Impact of Myopia and Its Complications on Quality of Life.
The P.A.U.S.E.® Spectacle Study
The A.R.R.E.S.T.® Spectacle Film Study
Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression
Myopia Control Using Bright Light Therapy, Myopic Defocus and Atropine
Artificial Intelligence for Highly Myopic Cataract
Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial
CYPRESS Efficacy and Safety Study Extension
Spectacle Lens Visual Acuity Assessments Study
Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness
Myopia Control Spectacle Lens Cessation Study
Assessment of DOT Spectacles in Chinese Children